Here’s a few on the stem cell issue:
by Charles Krauthammer
WASHINGTON — Last week, the White House invited me to a signing ceremony overturning the Bush (43) executive order on stem cell research. I assume this was because I have long argued in these columns and during my five years on the President’s Council on Bioethics that, contrary to the Bush policy, federal funding should be extended to research on embryonic stem cell lines derived from discarded embryos in fertility clinics.
I declined to attend. Once you show your face at these things you become a tacit endorser of whatever they spring. My caution was vindicated.
by Ken Connor
On Monday President Obama issued an executive order, removing the restrictions on federal funding for embryonic stem cell research (ESCR) instituted by former-President Bush. ESCR has provoked great controversy because it necessarily involves the destruction of nascent human life. Two alternative methods of stem cell research have seen great success and are free from ethical controversy, but Obama chose to ignore both ethics and pragmatism in his misguided commitment to support embryonic stem cell research with taxpayer money.
by Guy Benson
With a great deal of fanfare, President Obama signed an executive order on stem cell research last week. The most controversial element of his new directive is a short, harmless-looking clause that you probably haven’t heard about. People on all sides of the stem cell controversy should call this particular decision what it is: A disgrace.
Obama’s Embryonic Stem Cell OK Can Kill
By Michael Reagan
What President Obama did when he reversed President Bush’s executive order banning embryonic stem cell research was based not on solid science, but his desire to cater to the anti-life, pro-abortion forces and their media allies who helped elect him.
In doing this, he created the potential for an outbreak of potentially fatal cancerous tumors caused by the therapeutic use of embryonic stem cells.
Moreover, he killed another Bush presidential order that funded some of the most promising research on the creation of embryonic-like stem cells from harmless but potent adult stem cells.